Adjuvant chemotherapy for stage II colon cancer: who really needs it

BACKGROUND: Although there is evidence that failure to reach the baseline of 12–13 lymph nodes in resected specimens is related to poor prognosis of patients with stage II colon cancer, and may be a marker of adjuvant therapy, the use of these markers remains controversial. The objective of this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yan, Yang, Yang, Yang, Hui, Wang, Fen, Wang, Huihui, Chen, Qi, Liu, Ying, Li, Aiying, Zhang, Quanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087016/
https://www.ncbi.nlm.nih.gov/pubmed/30123000
http://dx.doi.org/10.2147/CMAR.S160886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087016/
https://www.ncbi.nlm.nih.gov/pubmed/30123000
http://dx.doi.org/10.2147/CMAR.S160886

Ejemplares similares